Oral Selective Janus Kinase (JAK) Inhibition: First Treatment to Achieve Complete Scalp Hair Regrowth (SALT = 0) in Phase 3 Human Trials
A major regulatory breakthrough was announced on April 28, 2026, as a once-daily pill called upadacitinib (brand name Rinvoq) was officially submitted to the FDA for the treatment of severe Alopecia Areata. This treatment has made history as the first of its kind to prove it can regrow 100% of lost scalp hair in a significant number of patients during the final stage of medical testing.
